Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), announce the companies have entered into a definitive merger agreement through which Alcon intends to acquire STAAR. Under the terms of the agreement, Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which represents approximately a 59% premium to STAAR’s 90-day Volume Weighted Average Price (VWAP) and a 51% premium to the closing price of STAAR common stock on August 4, 2025. The transaction represents a total equity value of approximately $1.5 billion.
Read the full article: Alcon Agrees to Acquire STAAR Surgical //
Source: https://www.businesswire.com/news/home/20250804959463/en/Alcon-Agrees-to-Acquire-STAAR-Surgical